תאי גזע מזנכמליים

Mesenchymal stem cells (MSCs) are multipotent stem cells originating from the embryonic ectoderm and mesoderm. They arise as epithelial cells from the epiblast, the developing embryo's outermost layer, then migrate inward and laterally. MSCs can differentiate into multiple connective tissue cell types and share similar morphology and gene expression with fibroblasts.

MSC differentiation depends on the mechanical properties of the extracellular matrix. On soft matrices, MSCs differentiate into adipocytes; on harder matrices, they differentiate into osteoblasts that form bone matrix. This matrix-dependent differentiation is crucial for proper tissue formation and regeneration.

The epithelial-to-mesenchymal transition is the process where epithelial cells from the epiblast transform into mesenchymal stem cells and migrate to form various tissues. This transition is essential for proper organ and tissue formation during embryonic development and enables MSCs to reach their target locations.

Adult MSCs can be isolated from various sources including bone marrow, placenta, adipose tissue, teeth, and Wharton's jelly in the umbilical cord. Bone-marrow-derived MSCs can differentiate into osteocytes, hepatocytes, pancreatic cells, and neuronal cells. Their accessibility and stability make them valuable for regenerative medicine applications.

Extracellular vesicles (EVs) released from MSCs facilitate immunomodulation by carrying nucleic acids, proteins, and paracrine signaling molecules to recipient cells. EVs can cross the blood-brain barrier and effectively trigger immune responses, making MSCs and EVs candidates for treating autoimmune disorders like rheumatoid arthritis.

MSCs exhibit contradictory effects in cancer: they can promote tumor growth by secreting growth factors that induce angiogenesis and facilitate invasion. However, MSCs also inhibit tumor cell cycle pathways and release cytotoxic factors to trigger programmed cell death. This dual nature makes MSCs a 'double-edged sword' in cancer therapy.

MSCs are similar to fibroblasts in morphology, gene expression, and differentiation potential. Both cell types originate from mesenchymal tissues and can differentiate into various connective tissue cell types. Understanding their similarities helps clarify MSC behavior and their role in tissue repair and regeneration.